Tivic Health to Report Q2 2024 Financial Results and Corporate Update on August 14th Via Conference Call and Webcast
06 8월 2024 - 10:15PM
Business Wire
Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a
health tech company that develops and commercializes bioelectronic
medicine, today announced that it will report its Q2 2024 financial
results and a corporate update via pre-recorded conference call and
webcast on Wednesday, August 14 at 1:30 PM PT / 4:30 PM ET. Current
shareholders, interested individuals and future investors are
encouraged to join the webcast to hear the company executives
provide a corporate update that will highlight the importance of
Tivic’s vagus nerve research program and its market potential. The
company invites questions to be submitted to ir@tivichealth.com by
August 11, 2024.
Teleconference Details:
Toll Free: 888-506-0062 International: 973-528-0011 Participant
Access Code: 316159
Webcast Link
https://www.webcaster4.com/Webcast/Page/2865/50901
About Tivic Health
Tivic Health is a commercial health tech company advancing the
field of bioelectronic medicine. Tivic Health’s technology
platforms leverage stimulation of the trigeminal, sympathetic, and
vagus nerve structures. Tivic Health’s non-invasive and targeted
approach to the treatment of inflammatory chronic health conditions
gives consumers and providers drug-free therapeutic solutions with
high safety profiles, low risk, and broad applications. Tivic
Health’s first commercial product ClearUP is an FDA approved,
award-winning, handheld bioelectronic sinus device. ClearUP is
clinically proven, doctor-recommended, and is available through
online retailers and commercial distributors. For more information
visit http://tivichealth.com @TivicHealth
Forward-Looking Statements
This press release may contain “forward-looking statements” that
are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press
release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of
words such as “anticipate,” “believe,” “contemplate,” “could,”
“estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,”
“potential,” “predict,” “project,” “target,” “aim,” “should,”
“will” “would,” or the negative of these words or other similar
expressions, although not all forward-looking statements contain
these words. Forward-looking statements are based on Tivic Health
Systems, Inc.’s current expectations and are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate.
Actual results could differ materially from those contained in any
forward-looking statement as a result of various factors.
Accordingly, you are cautioned not to place undue reliance on such
forward-looking statements. For a discussion of risks and
uncertainties relevant to the company, and other important factors,
see Tivic Health’s filings with the SEC, including, its Annual
Report on Form 10-K for the year ended December 31, 2023, filed
with the SEC on March 29, 2024, under the heading “Risk Factors”;
as well as the company’s subsequent filings with the SEC.
Forward-looking statements contained in this press release are made
as of this date, and Tivic Health Systems, Inc. undertakes no duty
to update such information except as required by applicable
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240806935582/en/
Media Contact: Morgan Luke
Morgan.Luke@tivichealth.com
Investor Contact: Hanover International, Inc.
ir@tivichealth.com
Tivic Health Systems (NASDAQ:TIVC)
과거 데이터 주식 차트
부터 7월(7) 2024 으로 8월(8) 2024
Tivic Health Systems (NASDAQ:TIVC)
과거 데이터 주식 차트
부터 8월(8) 2023 으로 8월(8) 2024